Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-88549968 |
Trade Name | |
Synonyms | JNJ88549968|JNJ 88549968 |
Drug Descriptions |
JNJ-88549968 is a bispecific antibody that targets CALR mutations and CD3, which potentially induces an immune response against tumor cells with CALR mutations and inhibits tumor growth (Blood (2023) 142 (Supplement 1): 1777). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-88549968 | JNJ-88549968 | 0 | 1 |